Flat open over Greek concerns

The markets opened flat with the Dow adding 11 points to 18,065 after the Greek parliament failed to elect a new president. Nasdaq edged up a fraction to 4,807.

On the upside

LIveDeal (Nasdaq: LIVE) reported record revenue for 2014.

Gilead Sciences (Nasdaq: GILD) expanded its agreement with Janssen to develop and commercialize the single tablet HIV treatment Complera which contains Gilead's tenofovir alafenamide and emtriciitabine and Janssen's rilpivirine.

Activist investor Carl Icahn acquired a 7.8% stake in Manitowoc (NYSE: MTW).

On the downside

Shares of National Bank of Greece (NYSE: NBG) fell after the Greek parliament failed to elect a new president.

Needham downgraded Ambarella (Nasdaq: AMBA) from a Hold rating to an Underperform rating.

Needham downgraded RF Micro Devices (Nasdaq: RFMD) from a Buy rating to a Hold rating.

In the broad market, advancing issues outpaced decliners by a margin of nearly 2 to 1 on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 added 2 points to 2091. Bitcoin edged up a fraction to $315.